XTL Biopharmaceuticals Ltd ADR (XTLB)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
5,406,700
EV to revenue ratio (TTM)
6.05
EV to ebitda
16.88
Financial Performance
Revenue (TTM)
968,000
Gross profit (TTM)
-2,254,000
EBITDA
-1,266,000
Profitability
Operating margin (TTM)
0.00%
Profit margin
0.00%
Return on assets (TTM)
-21.00%
Return on equity (TTM)
-29.30%
Per Share Metrics
Revenue per share (TTM)
0.4
EPS
-0.36
Diluted EPS (TTM)
-0.36
Book value
0
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
0
Price to sales ratio (TTM)
5.77
Price to book ratio (TTM)
1.897
Growth
Quarterly earnings growth (YoY)
0.00%
Quarterly revenue growth (YoY)
-76.00%
Analyst Sentiment
Strong buy
Buy
Hold
Sell
Strong sell
Risk & Volatility
Beta
0.453